Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study (Q39713866)

14 September 2017

title

Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study (English)

1 reference

14 September 2017

0 references

P Vabres

0 references

C Paul

0 references

E Guinard

1 reference

14 September 2017

C Bulai Livideanu

1 reference

14 September 2017

H Barthélémy

1 reference

14 September 2017

M Viguier

1 reference

14 September 2017

Z Reguiai

1 reference

14 September 2017

M A Richard

1 reference

14 September 2017

D Jullien

1 reference

14 September 2017

N Beneton

1 reference

14 September 2017

C Bara

1 reference

14 September 2017

A Grandvuillemin

1 reference

14 September 2017

M C Marguery

1 reference

14 September 2017

F Amelot

1 reference

14 September 2017

M P Konstantinou

1 reference

14 September 2017

H Bagheri

1 reference

14 September 2017

French Psoriasis Research Group

1 reference

14 September 2017

publication date

3 June 2016

1 reference

Journal of the European Academy of Dermatology and Venereology

14 September 2017

published in

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

1336-1341

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

14 September 2017

cites work

1 reference

Risk of tuberculosis infection in anti-TNF-α biological therapy: from bench to bedside

21 January 2018

1 reference

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

21 January 2018

1 reference

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry

21 January 2018

1 reference

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

21 January 2018

1 reference

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

21 January 2018

1 reference

Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization

21 January 2018

1 reference

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

21 January 2018

1 reference

Interferon gamma release assays: principles and practice

21 January 2018

1 reference

Gamma interferon release assays for detection of Mycobacterium tuberculosis infection

21 January 2018

1 reference

Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis

21 January 2018

1 reference

Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study

21 January 2018

1 reference

The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.

21 January 2018

1 reference

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

21 January 2018

1 reference

Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JDV.13633

1 reference

14 September 2017

1 reference